Ameriprise
ABBV icon

Ameriprise’s AbbVie ABBV Stock Holding History

Ameriprise’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-17,300
Closed -$1.31M – 3704
2019
Q3 		$1.31M Hold
17,300
– – ﹤0.01% 2896
2019
Q2 		$1.26M Buy
+17,300
New +$1.36M ﹤0.01% 2976
2016
Q1 		– Sell
-31,200
Closed -$1.85M – 3749
2015
Q4 		$1.85M Hold
31,200
– – ﹤0.01% 2646
2015
Q3 		$1.7M Buy
+31,200
New +$2.03M ﹤0.01% 2709

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ameriprise's ABBV Position: Q2 2026 in Review

Ameriprise increased its AbbVie (ABBV) stake by 4.1% in Q2 2026, buying an estimated $97.1M and bringing the position to 11,519,507 shares worth $2.9B. The position accounts for 0.59% of the portfolio, ranked #24.

Ameriprise first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Ameriprise held 11,519,507 shares of AbbVie worth $2.9B as of Q2 2026.
  • Ameriprise bought 451,197 AbbVie shares in Q2 2026, an estimated $97.1M.
  • AbbVie made up 0.59% of Ameriprise's portfolio in Q2 2026, its #24 holding.
  • Ameriprise first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.